Cargando…

Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3)

Ovarian cancer incidence continues to increase at an alarming rate. Although various therapeutic approaches exist for ovarian cancer, they have limitations, including undesired side effects. Therefore, nanoparticle (NP)-mediated therapy may be a viable, biocompatible, and suitable alternative. To th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gurunathan, Sangiliyandi, Qasim, Muhammad, Park, Chan Hyeok, Arsalan Iqbal, Muhammad, Yoo, Hyunjin, Hwang, Jeong Ho, Uhm, Sang Jun, Song, Hyuk, Park, Chankyu, Choi, Youngsok, Kim, Jin-Hoi, Hong, Kwonho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566439/
https://www.ncbi.nlm.nih.gov/pubmed/31121951
http://dx.doi.org/10.3390/nano9050787
_version_ 1783426852816158720
author Gurunathan, Sangiliyandi
Qasim, Muhammad
Park, Chan Hyeok
Arsalan Iqbal, Muhammad
Yoo, Hyunjin
Hwang, Jeong Ho
Uhm, Sang Jun
Song, Hyuk
Park, Chankyu
Choi, Youngsok
Kim, Jin-Hoi
Hong, Kwonho
author_facet Gurunathan, Sangiliyandi
Qasim, Muhammad
Park, Chan Hyeok
Arsalan Iqbal, Muhammad
Yoo, Hyunjin
Hwang, Jeong Ho
Uhm, Sang Jun
Song, Hyuk
Park, Chankyu
Choi, Youngsok
Kim, Jin-Hoi
Hong, Kwonho
author_sort Gurunathan, Sangiliyandi
collection PubMed
description Ovarian cancer incidence continues to increase at an alarming rate. Although various therapeutic approaches exist for ovarian cancer, they have limitations, including undesired side effects. Therefore, nanoparticle (NP)-mediated therapy may be a viable, biocompatible, and suitable alternative. To the best of our knowledge, no comprehensive analysis has been undertaken on the cytotoxicity and cellular pathways involved in ovarian cancer cells, particularly SKOV3 cells. Here, we investigated the effect of palladium NPs (PdNPs) and the molecular mechanisms and cellular pathways involved in ovarian cancer. We assayed cell viability, proliferation, cytotoxicity, oxidative stress, DNA damage, and apoptosis and performed an RNA-Seq analysis. The results showed that PdNPs elicited concentration-dependent decreases in cell viability and proliferation and induced increasing cytotoxicity at increasing concentrations, as determined by leakage of lactate dehydrogenase, increased levels of reactive oxygen species and malondialdehyde, and decreased levels of antioxidants like glutathione and superoxide dismutase. Furthermore, our study revealed that PdNPs induce mitochondrial dysfunction by altering mitochondrial membrane potential, reducing adenosine triphosphate levels, inducing DNA damage, and activating caspase 3, all of which significantly induced apoptosis in SKOV3 cells following PdNPs treatment. Gene ontology (GO) term analysis of PdNPs-exposed SKOV3 cells showed various dysregulated pathways, particularly nucleosome assembly, telomere organization, and rDNA chromatin silencing. When genes downregulated by PdNPs were applied to GO term enrichment analysis, nucleosome assembly was the top-ranked biological pathway. We also provide evidence for an association between PdNPs exposure and multiple layers of epigenetic transcriptional control and establish a molecular basis for NP-mediated apoptosis. These findings provide a foundation, potential targets, and novel insights into the mechanism underlying toxicity and pathways in SKOV3 cells, and open new avenues to identify novel targets for ovarian cancer treatment.
format Online
Article
Text
id pubmed-6566439
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65664392019-06-17 Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3) Gurunathan, Sangiliyandi Qasim, Muhammad Park, Chan Hyeok Arsalan Iqbal, Muhammad Yoo, Hyunjin Hwang, Jeong Ho Uhm, Sang Jun Song, Hyuk Park, Chankyu Choi, Youngsok Kim, Jin-Hoi Hong, Kwonho Nanomaterials (Basel) Article Ovarian cancer incidence continues to increase at an alarming rate. Although various therapeutic approaches exist for ovarian cancer, they have limitations, including undesired side effects. Therefore, nanoparticle (NP)-mediated therapy may be a viable, biocompatible, and suitable alternative. To the best of our knowledge, no comprehensive analysis has been undertaken on the cytotoxicity and cellular pathways involved in ovarian cancer cells, particularly SKOV3 cells. Here, we investigated the effect of palladium NPs (PdNPs) and the molecular mechanisms and cellular pathways involved in ovarian cancer. We assayed cell viability, proliferation, cytotoxicity, oxidative stress, DNA damage, and apoptosis and performed an RNA-Seq analysis. The results showed that PdNPs elicited concentration-dependent decreases in cell viability and proliferation and induced increasing cytotoxicity at increasing concentrations, as determined by leakage of lactate dehydrogenase, increased levels of reactive oxygen species and malondialdehyde, and decreased levels of antioxidants like glutathione and superoxide dismutase. Furthermore, our study revealed that PdNPs induce mitochondrial dysfunction by altering mitochondrial membrane potential, reducing adenosine triphosphate levels, inducing DNA damage, and activating caspase 3, all of which significantly induced apoptosis in SKOV3 cells following PdNPs treatment. Gene ontology (GO) term analysis of PdNPs-exposed SKOV3 cells showed various dysregulated pathways, particularly nucleosome assembly, telomere organization, and rDNA chromatin silencing. When genes downregulated by PdNPs were applied to GO term enrichment analysis, nucleosome assembly was the top-ranked biological pathway. We also provide evidence for an association between PdNPs exposure and multiple layers of epigenetic transcriptional control and establish a molecular basis for NP-mediated apoptosis. These findings provide a foundation, potential targets, and novel insights into the mechanism underlying toxicity and pathways in SKOV3 cells, and open new avenues to identify novel targets for ovarian cancer treatment. MDPI 2019-05-22 /pmc/articles/PMC6566439/ /pubmed/31121951 http://dx.doi.org/10.3390/nano9050787 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gurunathan, Sangiliyandi
Qasim, Muhammad
Park, Chan Hyeok
Arsalan Iqbal, Muhammad
Yoo, Hyunjin
Hwang, Jeong Ho
Uhm, Sang Jun
Song, Hyuk
Park, Chankyu
Choi, Youngsok
Kim, Jin-Hoi
Hong, Kwonho
Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3)
title Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3)
title_full Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3)
title_fullStr Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3)
title_full_unstemmed Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3)
title_short Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3)
title_sort cytotoxicity and transcriptomic analyses of biogenic palladium nanoparticles in human ovarian cancer cells (skov3)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566439/
https://www.ncbi.nlm.nih.gov/pubmed/31121951
http://dx.doi.org/10.3390/nano9050787
work_keys_str_mv AT gurunathansangiliyandi cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3
AT qasimmuhammad cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3
AT parkchanhyeok cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3
AT arsalaniqbalmuhammad cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3
AT yoohyunjin cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3
AT hwangjeongho cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3
AT uhmsangjun cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3
AT songhyuk cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3
AT parkchankyu cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3
AT choiyoungsok cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3
AT kimjinhoi cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3
AT hongkwonho cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3